TY - JOUR
T1 - Prefrontal cortex and amygdala volume in first minor or major depressive episode after cancer diagnosis
AU - Yoshikawa, Eisho
AU - Matsuoka, Yutaka
AU - Yamasue, Hidenori
AU - Inagaki, Masatoshi
AU - Nakano, Tomohito
AU - Akechi, Tatsuo
AU - Kobayakawa, Makoto
AU - Fujimori, Maiko
AU - Nakaya, Naoki
AU - Akizuki, Nobuya
AU - Imoto, Shigeru
AU - Murakami, Koji
AU - Kasai, Kiyoto
AU - Uchitomi, Yosuke
N1 - Funding Information:
This work was supported in part by a third-term comprehensive control research for cancer from the Japanese Ministry of Health, Labor, and Welfare; by a grant from the Japan Society for the Promotion of Science; and a grant from the Japanese Ministry of Education, Culture, Science, and Technology.
PY - 2006/4/15
Y1 - 2006/4/15
N2 - Background: Major and minor depressive episodes in cancer patients are frequent and are frequently seen as the first depressive episode in a patient's life. However, the neurological basis of these depressive episodes remains largely unknown. Methods: Subjects were 51 breast cancer survivors (BCS) who had no history of any depressive episode before the cancer diagnosis (11 BCS with a history of a first minor depressive episode after cancer diagnosis, 11 BCS with a history of a first major depressive episode after cancer diagnosis, and 29 BCS with no history of any depressive episode after cancer diagnosis). We analyzed the prefrontal cortex (PFC) and amygdala volumes in a 1.5-Tesla Magnetic Resonance Imaging scanner. We characterized the structural correlates of depression using two complementary approaches. The first was voxel-based morphometry (VBM) that allowed us to scan the entire brain for reactive gray matter deficit. The second was classical volumetry focusing on the amygdala. Results: Voxel-based morphometry revealed no brain region, including PFC, for which volume was significantly different among the three groups. There were trend-level differences in the left amygdala volume in the manual tracing method among the three groups. The left amygdala volumes in the subjects with a first minor and/or major depressive episode were significantly smaller than in those with no history of any depressive episode. Conclusions: It might be suggested that amygdala volume was associated with a first minor and/or major depressive episode after cancer diagnosis.
AB - Background: Major and minor depressive episodes in cancer patients are frequent and are frequently seen as the first depressive episode in a patient's life. However, the neurological basis of these depressive episodes remains largely unknown. Methods: Subjects were 51 breast cancer survivors (BCS) who had no history of any depressive episode before the cancer diagnosis (11 BCS with a history of a first minor depressive episode after cancer diagnosis, 11 BCS with a history of a first major depressive episode after cancer diagnosis, and 29 BCS with no history of any depressive episode after cancer diagnosis). We analyzed the prefrontal cortex (PFC) and amygdala volumes in a 1.5-Tesla Magnetic Resonance Imaging scanner. We characterized the structural correlates of depression using two complementary approaches. The first was voxel-based morphometry (VBM) that allowed us to scan the entire brain for reactive gray matter deficit. The second was classical volumetry focusing on the amygdala. Results: Voxel-based morphometry revealed no brain region, including PFC, for which volume was significantly different among the three groups. There were trend-level differences in the left amygdala volume in the manual tracing method among the three groups. The left amygdala volumes in the subjects with a first minor and/or major depressive episode were significantly smaller than in those with no history of any depressive episode. Conclusions: It might be suggested that amygdala volume was associated with a first minor and/or major depressive episode after cancer diagnosis.
KW - Amygdala
KW - Depressive disorder
KW - Magnetic resonance imaging
KW - Prefrontal cortex (PFC)
KW - Voxel-based morphometry (VBM)
UR - http://www.scopus.com/inward/record.url?scp=33645336811&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33645336811&partnerID=8YFLogxK
U2 - 10.1016/j.biopsych.2005.08.018
DO - 10.1016/j.biopsych.2005.08.018
M3 - Article
C2 - 16213471
AN - SCOPUS:33645336811
SN - 0006-3223
VL - 59
SP - 707
EP - 712
JO - Biological Psychiatry
JF - Biological Psychiatry
IS - 8
ER -